Brian C. Evanko - Aug 2, 2023 Form 4 Insider Report for Cigna Group (CI)

Signature
Kevin Ciaglo, attorney-in-fact
Stock symbol
CI
Transactions as of
Aug 2, 2023
Transactions value $
-$467,593
Form type
4
Date filed
8/4/2023, 05:21 PM
Previous filing
Mar 3, 2023
Next filing
Mar 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $180K +2.31K +7.36% $78.04 33.6K Aug 2, 2023 Direct F1
transaction CI Common Stock, $.01 Par Value Sale -$692K -2.31K -6.86% $300.00 31.3K Aug 2, 2023 Direct F1
transaction CI Common Stock, $.01 Par Value Options Exercise $44.5K +570 +1.82% $78.04 31.9K Aug 3, 2023 Direct F1
holding CI Common Stock, $.01 Par Value 869 Aug 2, 2023 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -2.31K -80.19% $0.00 570 Aug 2, 2023 Common Stock, $.01 Par Value 2.31K $78.04 Direct F1, F3
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -570 -100% $0.00* 0 Aug 3, 2023 Common Stock, $.01 Par Value 570 $78.04 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2023.
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F3 This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.